Cytomegalovirus Infection Leads to Microvascular Dysfunction and Exacerbates Hypercholesterolemia-Induced Responses

American Journal of Pathology

Volumn 177, Issue 4, 2010, Pages 2134-2144

  Khoretonenko, Mikhail V ^a   Leskov, Igor L ^a   Jennings, Stephen R ^a,b   Yurochko, Andrew D ^a   Stokes, Karen Y ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BLOOD CELL COUNT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE EXACERBATION; ENDOTHELIAL DYSFUNCTION; HYPERCHOLESTEROLEMIA; INFLAMMATION; LEUKOCYTE ADHERENCE; MICROVASCULATURE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTE ADHESION; VASODILATATION;

EID: 77957357563     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100307     Document Type: Article

References (61)

1. Bruggeman CA: Cytomegalovirus and latency: an overview. Virchows Arch B Cell Pathol Incl Mol Pathol 1993, 64:325-333
2. Chiu B, Viira E, Tucker W, Fong IW: Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997, 96:2144-2148
3. Blum A, Giladi M, Weinberg M, Kaplan G, Pasternack H, Laniado S, Miller H: High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 1998, 81:866-868
4. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, Hafner G, Prellwitz W, Schlumberger W, Meyer J: Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002, 33:2581-2586 (Pubitemid 35266427)
5. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989, 261:3561-3566
6. Kishore J, Ghoshal U, Ghoshal UC, Krishnani N, Kumar S, Singh M, Ayyagari A: Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol 2004, 53:1155-1160
7. Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA: Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001, 96:2137-2142
8. Soderberg-Naucler C: HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 2008, 41:218-223
9. Vliegen I, Duijvestijn A, Stassen F, Bruggeman C: Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis. Microbes Infect 2004, 6:1056-1062
10. Freeman RB Jr: The 'indirect' effects of cytomegalovirus infection. Am J Transplant 2009, 9:2453-2458
11. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE: Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 1999, 34:1738-1743
12. Bentz GL, Jarquin-Pardo M, Chan G, Smith MS, Sinzger C, Yurochko AD: Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J Virol 2006, 80:11539-11555
13. Smith MS, Bentz GL, Alexander JS, Yurochko AD: Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol 2004, 78:4444-4453
14. Burns LJ, Pooley JC, Walsh DJ, Vercellotti GM, Weber ML, Kovacs A: Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins.[see comment]. Transplantation 1999, 67:137-144
15. Dengler TJ, Raftery MJ, Werle M, Zimmermann R, Schonrich G: Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1beta. Transplantation 2000, 69:1160-1168
16. Knight DA, Waldman WJ, Sedmak DD: Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells. Transplantation 1999, 68:1814-1818
17. Ricotta D, Alessandri G, Pollara C, Fiorentini S, Favilli F, Tosetti M, Mantovani A, Grassi M, Garrafa E, Dei Cas L, Muneretto C, Caruso A: Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus. Cardiovasc Res 2001, 49:440-448
18. Shahgasempour S, Woodroffe SB, Garnett HM: Alterations in the expression of ELAM-1. ICAM-1 and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus. Microbiol Immunol 1997, 41:121-129
19. Span AH, Mullers W, Miltenburg AM, Bruggeman CA: Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers. Immunology 1991, 72:355-360
20. Craigen JL, Yong KL, Jordan NJ, MacCormac LP, Westwick J, Akbar AN, Grundy JE: Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology 1997, 92:138-145
21. Knight DA, Briggs BR, Bennett CF, Harindranath N, Waldman WJ, Sedmak DD: Attenuation of cytomegalovirus-induced endothelial intercellular adhesion molecule-1 mRNA/protein expression and T lymphocyte adhesion by a 2′-O-methoxyethyl antisense oligonucleotide. Transplantation 2000, 69:417-426
22. Rahbar A, Soderberg-Naucler C: Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol 2005, 79:2211-2220
23. Dansky HM, Barlow CB, Lominska C, Sikes JL, Kao C, Weinsaft J, Cybulsky MI, Smith JD: Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler Thromb Vasc Biol 2001, 21:1662-1667
24. Kitagawa K, Matsumoto M, Sasaki T, Hashimoto H, Kuwabara K, Ohtsuki T, Hori M: Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice. Atherosclerosis 2002, 160:305-310
25. Huo Y, Ley KF: Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 2004, 14:18-22
26. Nageh MF, Sandberg ET, Marotti KR, Lin AH, Melchior EP, Bullard DC, Beaudet AL: Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1997, 17:1517-1520
27. Libby P: Inflammation in atherosclerosis. Nature 2002, 420:868-874
28. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL: P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 2000, 191:189-194
29. Stokes K, Granger DN: The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolemia? J Physiol 2005, 562:647-653
30. Ishikawa M, Stokes KY, Zhang JH, Nanda A, Granger DN: Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin. Circ Res 2004, 94:239-244
31. Nellore K, Harris NR: Inhibition of leukocyte adherence enables venular control of capillary perfusion in streptozotocin-induced diabetic rats. Microcirculation 2004, 11:645-654
32. Stokes KY, Calahan L, Russell JM, Gurwara S, Granger DN: Role of platelets in hypercholesterolemia-induced leukocyte recruitment and arteriolar dysfunction. Microcirculation 2006, 13:377-388
33. Granger DN: Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation 1999, 6:167-178
34. Harris AG, Skalak TC, Hatchell DL: Leukocyte-capillary plugging and network resistance are increased in skeletal muscle of rats with streptozotocin-induced hyperglycemia. Int J Microcirc Clin Exp 1994, 14:159-166
35. Kurose I, Wolf RE, Grisham MB, Granger DN: Hypercholesterolemia enhances oxidant production in mesenteric venules exposed to ischemia/reperfusion. Arterioscler Thromb Vasc Biol 1998, 18:1583-1588
36. Mori N, Horie Y, Gerritsen ME, Granger DN: Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice. Am J Physiol 1999, 276:H1647-H1654
37. Panes J, Kurose I, Rodriguez-Vaca D, Anderson DC, Miyasaka M, Tso P, Granger DN: Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 1996, 93:161-167
38. Helantera I, Koskinen P, Tornroth T, Loginov R, Gronhagen-Riska C, Lautenschlager I: The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients. Transplantation 2003, 75:1858-1864
39. Koskinen PK, Nieminen MS, Krogerus LA, Lemstrom KB, Mattila SP, Hayry PJ, Lautenschlager IT: Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients. Transpl Int 1993, 6:341-347
40. Petrakopoulou P, Kubrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, Weis M: Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation 2004, 110:II207-II212
41. Marma AK, Lloyd-Jones DM: Systematic examination of the updated Framingham heart study general cardiovascular risk profile. Circulation 2009, 120:384-390
42. Burnett MS, Gaydos CA, Madico GE, Glad SM, Paigen B, Quinn TC, Epstein SE: Atherosclerosis in apoE knockout mice infected with multiple pathogens. J Infect Dis 2001, 183:226-231
43. Vliegen I, Duijvestijn A, Grauls G, Herngreen S, Bruggeman C, Stassen F: Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. Microbes Infect 2004, 6:17-24
44. Vliegen I, Stassen F, Grauls G, Blok R, Bruggeman C: MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice. J Clin Virol 2002, 25 (Suppl 2):S159-S171
45. Hsich E, Zhou YF, Paigen B, Johnson TM, Burnett MS, Epstein SE: Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. Atherosclerosis 2001, 156:23-28
46. Brune W, Hengel H, Koszinowski UH: A mouse model for cytomegalovirus infection. Curr Protoc Immunol 2001, Chapter 19:Unit 19-17
47. Cooper D, Chitman KD, Williams MC, Granger DN: Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2003, 284:G1027-G1033
48. Russell J, Cooper D, Tailor A, Stokes KY, Granger DN: Low venular shear rates promote leukocyte-dependent recruitment of adherent platelets. Am J Physiol Gastrointest Liver Physiol 2003, 284:G123-G129
49. Wheat RL, Clark PY, Brown MG: Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR. J Virol Methods 2003, 112:107-113
50. Gombos RB, Wolan V, McDonald K, Hemmings DG: Impaired vascular function in mice with an active cytomegalovirus infection. Am J Physiol Heart Circ Physiol 2009, 296:H937-H945
51. Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, Colhoun HM, Vallance P: Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 2003, 108:678-683
52. Span AH, Grauls G, Bosman F, van Boven CP, Bruggeman CA: Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis 1992, 93:41-52
53. Span AH, Frederik PM, Grauls G, Van Boven GP, Bruggeman CA: CMV induced vascular injury: an electron-microscopic study in the rat. In Vivo 1993, 7:567-573 (Pubitemid 24097488)
54. Smith MS, Bivins-Smith ER, Tilley AM, Bentz GL, Chan G, Minard J, Yurochko AD: Roles of phosphatidylinositol 3-kinase and NF-kappaB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence. J Virol 2007, 81:7683-7694
55. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW: Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003, 77:4588-4596
56. Yilmaz S, Koskinen PK, Kallio E, Bruggeman CA, Hayry PJ, Lemstrom KB: Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression. Kidney Int 1996, 50:526-537
57. Hendrix MG, Dormans PH, Kitslaar P, Bosman F, Bruggeman CA: The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol 1989, 134:1151-1157
58. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME: Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994, 42:170-174
59. Langer HF, Gawaz M: Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 2008, 99:480-486
60. Semple JW, Freedman J: Platelets and innate immunity. Cell Mol Life Sci 67:499-511
61. von Hundelshausen P, Koenen RR, Weber C: Platelet-mediated enhancement of leukocyte adhesion. Microcirculation 2009, 16:84-96